Transcranial alternating current stimulation as treatment for delirium: A multicenter randomized double-blind sham-controlled pilot study on safety and feasibility

Neurotherapeutics · Published 2026-08-04 · DOI 10.1016/j.neurot.2026.e01037

Free full text

Authors (10)

Julia van der A, D. Yorben Lodema, Edwin van Dellen, Indira Tendolkar, Marielle H. Emmelot-Vonk, Dennis J.L.G. Schutter, Willem de Haan, Mark van den Boogaard, Thomas H. Ottens, Arjen J.C. Slooter

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

A, J., Lodema, D., Dellen, E., et al. (2026). Transcranial alternating current stimulation as treatment for delirium: A multicenter randomized double-blind sham-controlled pilot study on safety and feasibility. Neurotherapeutics. https://doi.org/10.1016/j.neurot.2026.e01037

Related articles

• Huoling Shengji granule in amyotrophic lateral sclerosis: A multicenter, randomized, double-blind, riluzole-controlled trial · Neurotherapeutics · 2026 · Same journal
• PrPC modulates BACE1-dependent amyloid pathology under chronic cerebral hypoperfusion: Implications for vascular cognitive impairment · Neurotherapeutics · 2026 · Same journal
• Drug repurposing opportunities across 92 CNS-related conditions using deep learning and whole-genome sequencing · Neurotherapeutics · 2026 · Same journal
• Identifying treatment-responsive patient subgroups in a neutral clinical trial of Intensive blood pressure reduction in acute intracerebral hemorrhage: A post hoc explainable machine learning analysis · Neurotherapeutics · 2026 · Same journal
• Electric muscle stimulation attenuates neuroinflammation and improves the outcome of acute ischemic stroke in mice · Neurotherapeutics · 2026 · Same journal
• Bilateral intermittent theta burst stimulation over the primary motor cortex improves motor and affective symptoms via thalamic network reintegration in mid-stage Parkinson's disease · Neurotherapeutics · 2026 · Same journal
• Dual antiplatelet therapy in acute ischemic stroke: Does diabetes mellitus define a target population? · Neurotherapeutics · 2026 · Same journal
• Sex-specific considerations in migraine therapy · Neurotherapeutics · 2026 · Same journal
• PEBP1 inhibition as a therapeutic target for neurological recovery in ischemic stroke · Neurotherapeutics · 2026 · Same journal
• Hemodynamics Beyond Ischemic Zone Underlies Early Neurological Deterioration in Minor Stroke with Large Vessel Occlusion · Neurotherapeutics · 2026 · Same journal